The role of CEO is, subordinate to the Board of Directors and its main task is to carry out the daily management of Xbrane and the daily activities of the Company. The Board of Director’s rules of procedure and instructions for the CEO stipulate for which matters the Board of Directors is responsible to decide upon, and which decisions fall within the CEO’s area of responsibility. The CEO is also responsible for producing reports and necessary data for decision-making ahead of Board meetings and for presenting the material at Board meetings.

Xbrane has a management team consisting of nine people, which in addition to the CEO is comprised of the COO/Head of Biosimilars, CFO/Head of IR, CTO, Head of Manufacturing and Supply Chain, Head of Clinical Affairs, Head of Regulatory Affairs, Head of Business Development and Head of HR.

Management Team


Martin Åmark

Since 2015

Martin Åmark holds a M Sc. in industrial engineering and management from Linköping Institute of Technology and a MBA from INSEAD. He has 8 years of experience from Bain & Co as a management consultant. At Bain Martin worked mainly with M&A, strategy and organisation with Nordic clients across multiple industries, including life science and pharmaceuticals.

Shares: 175,073

COO & Head of Biosimilars

Siavash Bashiri

Since 2015

Siavash Bashiri holds a M Sc. in Molecular Biotechnology from Uppsala University. His latest position was with Agilent Technologies where he was the head of sales in EMEA for one of Agilent Technologies’ products within the Genomics department. He also has great knowledge of the commercialization of biotech start-ups from previous experiences.

Shares: 116,502

CFO & Head of IR

Anette Lindqvist

Since 2021

Anette Lindqvist has a degree in Business Administration from Gothenburg University of Economics. She has more than 25 years’ experience from the Life Science sector having held a number of Senior Finance & Business roles such as Global Clinical Finance Director at AstraZeneca, Head of Business Control at Swedish Orphan Biovitrum, Global CFO, SVP Finance Getinge Infection Control & Global CFO Operations & Supply Chain Mölnlycke Healthcare.

Shares: 14,000


Dr. David Vikström

Since 2014

David Vikström is the CTO of Xbrane Bioscience. He has a Ph.D. in expression and targeting of proteins in E. coli. He joined Xbrane in 2010 and successfully developed new technologies and strains for vaccine candidates. He is currently heading the development of Xbrane’s new expression systems to be able to take the expression in E. coli to new levels.

Shares: 33,153

Head of Manufacturing and Supply Chain

Anders Wallström

Since 2019

Anders Wallström holds a M. Sc. in Biotechnology from Royal Institute of Technology in Stockholm. He has more than 20 years of experience from process development, manufacturing and validation at SOBI and Biovitrum. Furthermore, he has significant experience from coordinating contract manufacturers for commercial products for both small molecule and biotech products.

Shares: 13,875

Head of Clinical Affairs

Dina Jurman

Since 2017

Dina Jurman holds a M.Sc. in Biomedicine from Uppsala University and has previously worked as Director Clinical Operations at IRW Consulting AB as well as Clinical Operations Manager consultant at Amgen Sweden.

Shares: 420

Head of Regulatory Affairs

Maria Edebrink

Since 2019

Maria Edebrink holds a M. Sc. in Chemistry from Stockholm University. She has 28 years of experience from Pharmaceutical Development and CMC Regulatory Affairs working for AstraZeneca, Galderma and Medivir. Her experience covers biotech products, small molecules, medical devices and cosmetics from early to late stage development through to commercial manufacturing.

Shares: 12,785

Chief Business Officer

Xiaoli Hu

Since 2020

Xiaoli joined Xbrane Biopharma in May 2020 as Head of Business Development. She brings 10+ years of biotechnology industry and medical science experience, including business development, corporate strategy, venture capital investment and life science research. Xiaoli most recently served as Business Development Director for Affibody AB, where she was instrumental to establish the co-development partnership with Alexion with potential value of USD 650 million. Prior to Affibody, Xiaoli worked as Associate Investor at HealthCap, a leading European life science VC investor.

Xiaoli holds a Ph.D. in Medicine from Karolinska Institute and an M.D. from Shanghai Jiao Tong University with two years of specialized training in general surgery.

Shares: –

Head of Human Relations

Nina Ivers

Since 2020

Nina Ivers holds a M. Sc. in Pharmacy and has studied Human Resources Mangagement at Uppsala and Stockholm University. She has more than 25 years of experience from different business roles and areas in life science companies like Astra, Johnson & Johnson and Swedish Orphan Biovitrum. She has experience from leading positions in marketing and sales as well as HR, most recently in a Global HR role at Sobi where she contributed to the growth of the company and development of the HR function.

Shares: 8,800

NamePositionMember of the senior management sinceEmployed at the Company sinceHoldings in Xbrane - SharesHoldings in Xbrane - WarrantsHoldings in Xbrane - Convertibles
Martin ÅmarkCEO20152015175,073--
Siavash BashiriCOO/Head of Biosimilars20122012116,502--
Anette LindqvistCFO/Head of IR2020202014,000--
David VikströmCTO2014201433,153--
Anders WallströmHead of Manufacturing and Supply Chain2020201913,875--
Dina JurmanHead of Clinical affairs20172017420--
Maria EdebrinkHead of Regulatory affairs2020201912,785--
Xiaoli Hu Chief Business Officer 20202020---
Nina Ivers Head of HR202020208,800--